Department of Medicine III and Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany.
Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.
Redox Biol. 2023 Apr;60:102616. doi: 10.1016/j.redox.2023.102616. Epub 2023 Feb 1.
Rheumatoid arthritis is an inflammatory joint disease in which synovial iron deposition has been described. Transferrin receptor 2 (Tfr2) represents a critical regulator of systemic iron levels. Loss of Tfr2 function in humans and mice results in iron overload. As iron contributes to inflammatory processes, we investigated whether Tfr2-deletion affects the pathogenesis of inflammatory arthritis in an iron-dependent manner.
Using a global and conditional genetic disruption of Tfr2, we assessed the relevance of Tfr2 in K/BxN serum-transfer arthritis (STA) and macrophage polarization.
Male Tfr2 mice subjected to STA developed pronounced joint swelling, and bone erosion as compared to Tfr2 littermate-controls (P < 0.01). Furthermore, an increase of neutrophils and macrophages/monocytes was observed in the inflammatory infiltrate within the paws of Tfr2 mice. To elucidate whether Tfr2 in myeloid cells has a direct role in the pathogenesis of arthritis or whether the effects were mediated via the systemic iron overload, we induced STA in Tfr2-LysMCre + mice, which showed normal iron-loading. Cre + female mice displayed increased disease development compared to Cre-controls. As macrophages regulate iron availability and innate immunity, we hypothesized that Tfr2-deficiency would polarize macrophages toward a pro-inflammatory state (M1) that contributes to arthritis progression. In response to IFN-γ stimulation, Tfr2 macrophages showed increased expression of M1-like cytokines, IFN-γ-target genes, nitric-oxide production, and prolonged STAT1 activation compared to Tfr2 macrophages (P < 0.01), while pre-treatment with ruxolitinib abolished Tfr2-driven M1-like polarization.
Taken together, these findings suggest a protective role of Tfr2 in macrophages on the progression of arthritis via suppression of M1-like polarization.
类风湿关节炎是一种炎症性关节疾病,其中已描述了滑膜铁沉积。转铁蛋白受体 2(Tfr2)是调节系统铁水平的关键调节剂。人类和小鼠 Tfr2 功能丧失会导致铁过载。由于铁会促进炎症过程,我们研究了 Tfr2 缺失是否以铁依赖性方式影响炎症性关节炎的发病机制。
使用 Tfr2 的全局和条件基因缺失,我们评估了 Tfr2 在 K/BxN 血清转移关节炎(STA)和巨噬细胞极化中的相关性。
与 Tfr2 同窝对照相比,接受 STA 的雄性 Tfr2 小鼠表现出明显的关节肿胀和骨侵蚀(P < 0.01)。此外,在 Tfr2 小鼠的炎症浸润中观察到中性粒细胞和巨噬细胞/单核细胞增加。为了阐明 Tfr2 在髓样细胞中是否直接参与关节炎的发病机制,或者这些影响是否通过系统铁过载介导,我们在 Tfr2-LysMCre + 小鼠中诱导 STA,其表现出正常的铁负荷。Cre + 雌性小鼠与 Cre 对照相比,疾病发展增加。由于巨噬细胞调节铁的可用性和先天免疫,我们假设 Tfr2 缺失会使巨噬细胞向有助于关节炎进展的促炎状态(M1)极化。在 IFN-γ 刺激下,与 Tfr2 巨噬细胞相比,Tfr2 缺陷型巨噬细胞表现出更高水平的 M1 样细胞因子、IFN-γ 靶基因、一氧化氮产生和 STAT1 激活(P < 0.01),而预先用鲁索利替尼治疗则消除了 Tfr2 驱动的 M1 样极化。
总之,这些发现表明 Tfr2 在巨噬细胞中通过抑制 M1 样极化对关节炎的进展具有保护作用。